Search

Displaying 61 - 70 of 1989

Statement from Kevin Longino, CEO of the National Kidney Foundation (NKF) and a transplant recipient, on the Senate’s unanimous passage of the U.S. Organ Procurement and Transplantation Network (OPTN) Act

(July 28, 2023 – New York, NY) – “There are more than 800,000 Americans living with kidney failure, and more than 100,000 of them are on the transplant waiting list. Fourteen people will die each day before they get...

 

               National Kidney Foundation and Medtronic survey found dialysis patients’ top concerns potentially better addressed by minimally invasive AV fistula creation procedures

(July 21, 2023, New York, NY) - A survey recently conducted by Medtronic and the National Kidney Foundation (NKF) found that patients undergoing hemodialysis lack awareness about minimally...

On behalf of the 37 million adults in America with kidney diseases, including the over 90 percent who are unaware that they have chronic kidney disease, the American Society of Nephrology and the National Kidney Foundation express our concern that the...

~National Kidney Foundation & American Association for Clinical Chemistry Urges an End to Race-Based eGFR Equations and Addresses Critical Healthcare Needs of Transgender and Gender-Diverse Individuals~

(New York, NY – June 28, 2023) –The National Kidney Foundation (NKF) and the American Association for Clinical Chemistry (AACC) continue to challenge the status quo in kidney care through a report titled "Advancing...

~Comprehensive Commentary Provides Insights and Implementation Guidance for US Healthcare Professionals by NKF and KDOQI~

(New York, NY – Wednesday, June 21, 2023) – The National Kidney Foundation (NKF) and its Kidney Disease Outcomes Quality Initiative (KDOQI) are pleased to announce the publication of the KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. This...

June 12, 2023, New York, NY —The National Kidney Foundation (NKF) is proud to announce its latest investment through the NKF's Innovation Fund in Klinrisk, an artificial intelligence-based medical device company. Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction and decision support.

...

(June 1, 2023, New York, NY) — The National Kidney Foundation (NKF) is thrilled to announce the appointment of Dr. John Wigneswaran (Dr. Wig), Walmart’s Chief Medical Officer, to NKF’s National Board of Directors. In his role at Walmart, Dr. Wig leads safety, quality, and training, the Walmart Healthcare Research Institute...

~Jaime Herrera Beutler of Clark County, Washington joins the fight against kidney disease ~

(June 1, 2023, New York, NY) — The National Kidney Foundation (NKF) is excited to announce the appointment of Jaime Herrera Beutler, former U.S. Congresswoman and Washington state legislator, to its National Board...

The National Kidney Foundation (NKF) is remembering Dr. Shaul G. Massry, a trailblazer and leader in the nephrology community and at the National Kidney Foundation. A statement from Kevin Longino, CEO of NKF follows:

“Dr. Massry served the National Kidney Foundation (NKF) with great distinction and influence since 1968, first as an active member of the Southern California affiliate and then at the National level. Through his...